National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Fibromyalgia is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Muscular Rheumatism
- Musculoskeletal Pain Syndrome
- Nonarticular Rheumatism
- Periarticular Fibrositis
- Rheumatoid Myositis
- Tension Myalgia
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Chronic Fatigue Syndrome
- Polymyalgia Rheumatica
- Rheumatoid Arthritis
- Sjögren Syndrome
- Temporomandibular Dysfunction
Fibromyalgia is a chronic disorder characterized by pain throughout much of the body. The pain may begin gradually or have a sudden onset. Other symptoms are muscle spasms, fatigue, muscle tissue stiffness and non- restorative (unrefreshing) sleep. The exact cause of this disorder is unknown.
The terms Fibrositis, Fibromyositis, Periarticular Fibrositis and Rheumatoid Myositis are still being used by many to describe this condition. The ending of "itis" on each of these terms is actually incorrect. "Itis" means inflammation, and there is no inflammation in Fibromyalgia. The term Fibromyalgia has now become the accepted term, but many people continue to be diagnosed with the other synonyms. Tension Myalgia is another synonym that is currently being used.
Patients with Fibromyalgia may have a gradual or sudden onset of symptoms. The major symptom of this disorder is muscular pain. Areas which are frequently affected may include muscles in the back of the neck and shoulders, in the low back, the sides of the breast bone, and the bony points of the elbows, hips and knees. In addition, small specific areas called tender points, which are painful when pressure is applied, will be found by an examining physician.
Other symptoms found in most patients with Fibromyalgia are: muscle spasms, fatigue, muscle stiffness and non-restorative (unrefreshing) sleep.
Some patients with fibromyalgia may have chest pain, painful menstrual periods, difficulty concentrating, headaches, painful and/or frequent urination, diarrhea, constipation, numbness, dryness in the eyes and mouth, dizziness, swelling of a tendon (tendinitis), swelling of the connective tissue structure surrounding a joint (bursitis), depression and/or anxiety.
The exact cause of Fibromyalgia is not known. Researchers are studying serotonin, a chemical in the brain (neurotransmitter), to see if there is a disturbance in the messages sent between various parts of the central nervous system in people with Fibromyalgia. An imbalance of serotonin could have a hand in the increase of pain, depression and unrefreshing sleep associated with Fibromyalgia.
Muscle tissue, hormonal and immunological influences, as well as the possibility of a virus triggering the disorder are all being investigated by researchers.
Fibromyalgia is diagnosed more frequently in females than in males. The majority of patients with this disorder will develop symptoms between the ages of 20 and 50 years. It is estimated that 3.7 million Americans are affected by Fibromyalgia.
Fibromyalgia may also develop in children and teenagers, often being misdiagnosed as "growing pains."
Symptoms of the following disorders can be similar to those of Fibromyalgia. Comparisons may be useful for a differential diagnosis:
Chronic Fatigue Syndrome (CFS) is a disorder characterized by profound fatigue and other related symptoms. Standards for the diagnosis of CFS have been defined by researchers and the Centers for Disease Control (CDC). These include excessive fatigue or easy fatigability that does not respond to bed rest. The fatigue is severe enough to reduce the average daily activities of the affected individual by at least fifty percent. The onset of these symptoms is usually sudden, sometimes following a flu-like illness. According to the CDC, the profound fatigue must last for at least six months in order for the diagnosis to be made. Scientists believe Chronic Fatigue Syndrome is not contagious and laboratory tests (blood, urine, etc.) are of little value in diagnosing the syndrome. (For more information on this disorder, choose "Chronic Fatigue Syndrome" as your search term in the Rare Disease Database.)
Polymyalgia Rheumatica is a disorder characterized by pain and stiffness in certain muscle groups without causing permanent weakness or atrophy. The major symptoms of this disorder are pain and stiffness in the neck, shoulders, upper arms, lower back, hips and thighs. The symptoms often appear suddenly and the stiffness is most severe in the morning. The pain of PMR is felt on both sides of the body. Fever, lack of appetite, fatigue, weight loss and depression may also be present. (For more information on this disorder, choose "Polymyalgia" as your search term in the Rare Disease Database.)
Polymyositis is a systemic connective tissue disorder characterized by inflammatory and degenerative changes in the muscles, leading to weakness and some degree of muscle atrophy. The areas principally affected are the hip, shoulders, arms, pharynx and neck. Other symptoms of Polymyositis may include fever, weight loss and occasional pain or tenderness in muscles or joints. The exact cause of this disorder is not known. (For more information on this disorder, choose "Polymyositis" as your search term in the Rare Disease Database.)
Rheumatoid Arthritis is an inflammatory autoimmune disease in which the body's natural defenses against foreign agents (antibodies & lymphocytes) attack healthy joints. This disorder is characterized by a lack of appetite, fatigue, painful and deformed joints, early morning stiffness chiefly in the hands, knees, feet, jaw and spine. (For more information on this disorder, choose "Arthritis" as your search term in the Rare Disease Database.)
Sjögren Syndrome is a degeneration of the mucous secreting glands, particularly the tear and saliva glands. It is sometimes associated with arthritis. There is often a gritty, burning sensation in the eyes due to the loss of lubrication. When the mouth becomes dry, chewing and swallowing food is difficult. The lack of saliva causes particles of food to stick to the cheeks, gums and throat. Other symptoms of Sjögren Syndrome include a weak voice, dental decay, sensitivity of the eyes to the light, swelling of the salivary glands, and dryness of the nose, skin and vagina. Fibromyalgia may occur in conjunction with Sjögren's Syndrome. (For more information on this disorder choose "Sjögren" as your search term in the Rare Disease Database.)
Temporomandibular Joint Dysfunction (TMJ) is a painful disorder of the jaw joint which is made worse during or after eating or yawning. This disorder may cause limited jaw movement and clicks and pops during chewing. In severe cases pain may radiate into the neck, shoulders and back, mimicking the pain of Fibromyalgia. (For more information on this disorder choose "Temporomandibular Joint Dysfunction" as your search term in the Rare Disease Database.)
Fibromyalgia may be treated with low doses of tricyclic antidepressant medications. Amitriptyline (Elavil) and Cyclobenzaprine (Flexeril), which are prescribed as muscle relaxants, may be helpful. They may also help patients who suffer from unrefreshing (non-restorative) sleep. The tricyclic antidepressant amitriptyline (Elavil) can also be used to help patients with this disorder who have depression. When Elavil is used for this reason, it is given at higher doses.
Some patients receive temporary relief with stretching exercises, deep heat treatments, warm showers and baths, whirlpool baths and hot tubs, heating pads, massages, ice packs, acupuncture, biofeedback and/or aerobic exercise.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Bennett JC, Plum F, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia, PA: W.B. Saunders Co; 1996:1527, 2037
Adams, RD, et al., eds. Principles of Neurology. 6th ed. New York, NY: McGraw-Hill, Companies; 1997:1494-95.
Kelley WN, et al., eds. Textbook of Rheumatology. 4th ed. Philadelphia, PA: W.B. Saunders Company; 1993:471-2, 474-78.
Fibromyalgia: Mary Anne Saathoff BSN, Fibromyalgia Association of Central Ohio (1991).
Evcik D, et al. The effects of balneotherapy on fibromyalgia patients. Rheumatol Int. 2002;22;5-9.
Arnold LM, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;15:191-97.
Siegel DM, et al. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics. 1998;101:377-82.
Smart PA, et al. Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil. 1997;76:231-34.
Bendtsen L, et al. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum. 1997;40:98-102.
Aaron LA, et al. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum. 1997;40:453-60.
Zucker DR, et al. Combining single patient (n-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol. 1997;50:401-10.
Krsnich-Shriwise S, et al. Fibromyalgia syndrome: an overview. Phys Ther. 1997;77:68-75.
Mannerkorpi K, et al. Assessment of functional limitation and disability in patients with fibromyalgia. Scand J Rheumatol. 1997;26:4-13.
Wallace DJ. The fibromyalgia syndrome. Ann Med. 1997;29:9-21.
Wolfe F, et al. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 1997;24:555-59.
Buskila D, et al. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol. 1997;24:941-44.
National Chronic Fatigue Syndrome & Fibromyalgia Association
P.O. Box 18426
Kansas City, MO 64133
American Chronic Pain Association
P.O. Box 850
Rocklin, CA 95677
American Autoimmune Related Diseases Association, Inc.
22100 Gratiot Ave.
Eastpointe, MI 48021
1330 West Peachtree Street, Suite 100
Atlanta, GA 30309
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
One AMS Circle
Bethesda, MD 20892-3675
National CFIDS Foundation, Inc.
103 Aletha Road
Needham, MA 02492-3931
P.O. Box 9204
Bardonia, NY 10954
Erythema Nodosum Yahoo Support Group
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
PO Box 241956
Los Angeles, CA 90024
Autoimmune Information Network, Inc.
PO Box 4121
Brick, NJ 08723
Irish Chronic Pain Association
Coleraine House, Coleraine St.
11688 North Sage Brook Road
Oro Valley, AZ 85737-7342
European Society for Immunodeficiencies
1-3 rue de Chantepoulet
Geneva, CH 1211
Global Healthy Living Foundation (GHLF)
515 N. Midland Ave.
Upper Nyack, NY 10960
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 3/24/2008
Copyright 1991, 1993, 1996, 1997, 1998, 1999, 2002 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.